BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Musaku Mwenechanya"”

16+ results

Standardized Interpretation of Chest Radiographs in Cases of Pediatric Pneumonia From the PERCH Study

Verified

Nicholas Fancourt, Maria Deloria Knoll, Breanna Barger-Kamate, John de Campo et al.

Journal: Clinical Infectious DiseasesYear: 2017Citations: 80

BACKGROUND.: Chest radiographs (CXRs) are a valuable diagnostic tool in epidemiologic studies of pneumonia. The World Health Organization (WHO) methodology for the interpretation of pediatric CXRs has not been evaluated beyond its intended application as an endpoint measure for bacterial vaccine tri...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth

Verified

Alan Tita, Waldemar A. Carlo, Elizabeth M. McClure, Musaku Mwenechanya et al.

Journal: New England Journal of MedicineYear: 2023Citations: 73

BACKGROUND: The use of azithromycin reduces maternal infection in women during unplanned cesarean delivery, but its effect on those with planned vaginal delivery is unknown. Data are needed on whether an intrapartum oral dose of azithromycin would reduce maternal and offspring sepsis or death. METHO...

Health SciencesMedicineSurgeryOpen Access
Read Source

Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia—Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii

Verified

Daniel E. Park, Henry C. Baggett, Stephen R. C. Howie, Qiyuan Shi et al.

Journal: Clinical Infectious DiseasesYear: 2017Citations: 66

BACKGROUND.: There is limited information on the association between colonization density of upper respiratory tract colonizers and pathogen-specific pneumonia. We assessed this association for Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii. METHODS....

Health SciencesMedicineEpidemiologyOpen Access
Read Source

Prevention of maternal and neonatal death/infections with a single oral dose of azithromycin in women in labour in low-income and middle-income countries (A-PLUS): a study protocol for a multinational, randomised placebo-controlled clinical trial

Verified

Jennifer Hemingway‐Foday, Alan Tita, Elwyn Chomba, Musaku Mwenechanya et al.

Journal: BMJ OpenYear: 2023Citations: 11

INTRODUCTION: Maternal and neonatal infections are among the most frequent causes of maternal and neonatal mortality, and current antibiotic strategies have been ineffective in preventing many of these deaths. A randomised clinical trial conducted in a single site in The Gambia showed that treatment...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

Effectiveness of intrapartum azithromycin to prevent infections in planned vaginal births in low-income and middle-income countries: a post-hoc analysis of data from a multicentre, randomised, double-blind, placebo-controlled trial

Verified

Waldemar A. Carlo, Alan Tita, Janet Moore, Musaku Mwenechanya et al.

Journal: The Lancet Global HealthYear: 2025Citations: 8

BACKGROUND: In 2023, the Azithromycin Prevention in Labor Use (A-PLUS) trial showed intrapartum azithromycin reduces maternal sepsis or death in women with planned vaginal delivery in low-resource settings, but whether it reduces maternal infection is unknown. We aimed to evaluate the effectiveness ...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

Intrapartum and postpartum antibiotic use in seven low‐ and middle‐income countries: Findings from the A‐PLUS trial

Verified

Sarah Saleem, Haleema Yasmin, Janet Moore, Anum Rahim et al.

Journal: BJOG An International Journal of Obstetrics & GynaecologyYear: 2024Citations: 6

OBJECTIVE: To describe the intrapartum and postpartum use of non-study antibiotics in low- and middle-income countries (LMICs) during the double-blinded NICHD Global Network Azithromycin in Labor (A-PLUS) trial. DESIGN: The antibiotic use sub-study was a planned prospective, observational sub-study ...

Life SciencesImmunology and MicrobiologyApplied Microbiology and BiotechnologyOpen Access
Read Source

<scp>COVID</scp>‐19 antibody positivity over time and pregnancy outcomes in seven low‐and‐middle‐income countries: A prospective, observational study of the Global Network for Women's and Children's Health Research

Verified

Robert L. Goldenberg, Sarah Saleem, Sk Masum Billah, Jean Kim et al.

Journal: BJOG An International Journal of Obstetrics & GynaecologyYear: 2022Citations: 6

OBJECTIVES: To determine COVID-19 antibody positivity rates over time and relationships to pregnancy outcomes in low- and middle-income countries (LMICs). DESIGN: With COVID-19 antibody positivity at delivery as the exposure, we performed a prospective, observational cohort study in seven LMICs duri...

Health SciencesMedicineObstetrics and GynecologyOpen Access
Read Source

PRIORITY Trial – Prevention of Iron Deficiency Anemia Post-Delivery: A randomized controlled trial comparing the effectiveness of single-dose intravenous iron with oral iron in the treatment of moderate iron deficiency anemia in postpartum women

Verified

Richard J. Derman, Shivaprasad S. Goudar, Mrityunjay Metgud, Avinash Kavi et al.

Year: 2025Citations: 4
Health SciencesMedicineHematology
Read Source

Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial

Verified

Jackie K. Patterson, Simon Neuwahl, Sydney Kirsch, Janet Moore et al.

Journal: The Lancet Global HealthYear: 2025Citations: 4

BACKGROUND: Sepsis is one of the leading causes of maternal mortality globally. In 2023, the Azithromycin Prevention in Labor Use (A-PLUS) trial showed intrapartum azithromycin for women planning a vaginal birth reduced the risk of maternal sepsis or death and infection. We aimed to evaluate the cos...

Health SciencesMedicinePublic Health, Environmental and Occupational HealthOpen Access
Read Source

COVID‐19 symptoms and antibody positivity among unvaccinated pregnant women: An observational study in seven countries from the Global Network

Verified

Avinash Kavi, Shivaprasad S. Goudar, Manjunath S. Somannavar, Janet Moore et al.

Journal: BJOG An International Journal of Obstetrics & GynaecologyYear: 2023Citations: 3

OBJECTIVE: To determine the relation of COVID-19 symptoms to COVID-19 antibody positivity among unvaccinated pregnant women in low- and middle-income countries (LMIC). DESIGN: COVID-19 infection status measured by antibody positivity at delivery was compared with the symptoms of COVID-19 in the curr...

Health SciencesMedicineObstetrics and GynecologyOpen Access
Read Source

The Global Network <scp>COVID</scp>‐19 studies: a review

Verified

Seemab Naqvi, Sarah Saleem, Sk Masum Billah, Janet Moore et al.

Journal: BJOG An International Journal of Obstetrics & GynaecologyYear: 2023Citations: 2

With the paucity of data available regarding COVID-19 in pregnancy in low- and middle-income countries (LMICs), near the start of the pandemic, the Global Network for Women's and Children's Health Research, funded by the National Institute of Child Health and Human Development (NICHD), initiated fou...

Health SciencesMedicineObstetrics and GynecologyOpen Access
Read Source

Antibiotic use in infants in the 6 weeks after delivery in seven low- and middle-income countries: findings from the A-PLUS trial

Verified

Haleema Yasmin, Saba Tanveer, Shiyam Sunder Tikmani, Janet Moore et al.

Journal: Paediatrics and International Child HealthYear: 2024Citations: 1

OBJECTIVES: Antibiotic use is increasing in low- and middle-income countries (LMIC); however, few studies have examined the rates of use in a population. The use of antibiotics for liveborn infants in LMIC was examined. DESIGN: The study, a planned prospective, observational secondary analysis of th...

Life SciencesImmunology and MicrobiologyApplied Microbiology and BiotechnologyOpen Access
Read Source

Intrapartum oral azithromycin for maternal infection prophylaxis and the risk of postpartum hemorrhage: A secondary analysis of the A‐ <scp>PLUS</scp> trial

Verified

Larissa Kamgue Sidze, Janet L. Moore, Waldemar A. Carlo, Musaku Mwenechanya et al.

Journal: International Journal of Gynecology & ObstetricsYear: 2026

OBJECTIVE: A single oral dose of azithromycin (AZM) given during labor to women planning a vaginal delivery reduced maternal infections including sepsis, with a stronger effect in sub-Saharan Africa than South Asia. Since maternal infection contributes to labor dysfunction and postpartum hemorrhage ...

Health SciencesMedicinePediatrics, Perinatology and Child HealthOpen Access
Read Source

Non‐study post‐partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A‐ <scp>PLUS</scp> randomized controlled trial

Verified

Elizabeth M. McClure, Alan T N Tita, Waldemar A. Carlo, Sarah Saleem et al.

Journal: International Journal of Gynecology & ObstetricsYear: 2026

OBJECTIVE: The randomized trial of azithromycin to reduce maternal and neonatal sepsis (the A-PLUS Trial) found substantial reduction in maternal sepsis among women receiving azithromycin and substantial non-study antibiotic use. This secondary analysis explored the effect modification of non-study ...

Health SciencesMedicinePublic Health, Environmental and Occupational HealthOpen Access
Read Source

Timing of Prophylactic Intrapartum Azithromycin Administration and Efficacy in Prevention of Maternal and Infant Infections: A Secondary Analysis of a Randomized Controlled Trial

Verified

Rupsa C. Boelig, Avinash Kavi, Janet Moore, Denise C. Babineau et al.

Journal: BJOG An International Journal of Obstetrics & GynaecologyYear: 2026

OBJECTIVE: A multi-centre international trial (A-PLUS), demonstrated that a single dose of 2 g oral azithromycin in labour reduced the risk of maternal sepsis or death, but not neonatal mortality. We aimed to determine whether the efficacy of azithromycin in prevention of any maternal infection or n...

Health SciencesMedicinePublic Health, Environmental and Occupational HealthOpen Access
Read Source
PreviousPage 1 of 2+Next